Mason; Andrew McMurtrie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mason; Andrew McMurtrie.The latest application filed is for "novel compounds".
Company Profile
0.24.36
- Mason; Andrew McMurtrie - Stevenage GB
- Mason; Andrew McMurtrie - Hertfordshire GB
- Mason; Andrew McMurtrie - Stevenage Hertfordshire GB
- Mason; Andrew McMurtrie - Research Triangle Park NC
Patent Activity
| Patent | Date |
|---|---|
| Compounds Grant 9,408,851 - Borthwick , et al. August 9, 2 | 2016-08-09 |
| Novel Compounds App 20160030442 - Borthwick; Alan David ; et al. | 2016-02-04 |
| Novel Compounds App 20150157640 - Borthwick; Alan David ; et al. | 2015-06-11 |
| Compounds Grant 8,742,099 - Borthwick , et al. June 3, 2 | 2014-06-03 |
| Novel Compounds App 20130253188 - Borthwick; Alan David ; et al. | 2013-09-26 |
| Substituted diketopiperazines as oxytocin antagonists Grant 8,541,579 - Borthwick , et al. September 24, 2 | 2013-09-24 |
| Substituted Diketopiperazines As Oxytocin Antagonists App 20130131338 - Borthwick; Alan David ; et al. | 2013-05-23 |
| Substituted diketopiperazines as oxytocin antagonists Grant 8,367,673 - Borthwick , et al. February 5, 2 | 2013-02-05 |
| Novel Processes App 20120220779 - Crawford; Claire Frances ; et al. | 2012-08-30 |
| Novel Compounds App 20120202811 - Borthwick; Alan David ; et al. | 2012-08-09 |
| Compounds Grant 8,202,864 - Borthwick , et al. June 19, 2 | 2012-06-19 |
| Xanthine derivatives as selective HM74A agonists Grant 8,143,264 - Hatley , et al. March 27, 2 | 2012-03-27 |
| Xanthine Derivatives As Selective Hm74a Agonists App 20110257205 - HATLEY; Richard Jonathan Daniel ; et al. | 2011-10-20 |
| Novel Compounds App 20110152262 - Borthwick; Alan David ; et al. | 2011-06-23 |
| Compounds Grant 7,919,492 - Borthwick , et al. April 5, 2 | 2011-04-05 |
| Novel Compounds App 20100305127 - Borthwick; Alan David ; et al. | 2010-12-02 |
| Xanthine Derivatives As Selective Hm74a Agonists App 20100179128 - Hatley; Richard Jonathan Daniel ; et al. | 2010-07-15 |
| Xanthine Derivatives As Selective Hm74a Agonists App 20100168122 - Hatley; Richard Jonathan Daniel ; et al. | 2010-07-01 |
| Naphthalene derivatives Grant 7,732,622 - Congreve , et al. June 8, 2 | 2010-06-08 |
| Novel compounds App 20090247541 - Borthwick; Alan David ; et al. | 2009-10-01 |
| Substituted Diketopiperazines As Oxytocin Antagonists App 20090186867 - Borthwick; Alan David ; et al. | 2009-07-23 |
| Piperazinediones as oxytocin receptor antagonists Grant 7,550,462 - Borthwick , et al. June 23, 2 | 2009-06-23 |
| Pyrrolidine derivatives as factor Xa inhibitors Grant 7,517,879 - Chan , et al. April 14, 2 | 2009-04-14 |
| Substituted diketopiperazines as oxytocin antagonists Grant 7,514,437 - Borthwick , et al. April 7, 2 | 2009-04-07 |
| Pyrrolidine derivatives as factor Xa inhibitors Grant 7,429,587 - Chan , et al. September 30, 2 | 2008-09-30 |
| Naphthalene Derivatives App 20080234358 - Congreve; Miles Stuart ; et al. | 2008-09-25 |
| Anthranilic Acid Derivatives As Hm74A Receptor Agonists App 20080221108 - Hatley; Richard ; et al. | 2008-09-11 |
| Anthranilic Acid Derivatives Active as the Hm74a Receptor App 20080214638 - Mason; Andrew McMurtrie ; et al. | 2008-09-04 |
| Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia App 20080139565 - Campbell; Matthew ; et al. | 2008-06-12 |
| 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases Grant 7,329,685 - Borthwick , et al. February 12, 2 | 2008-02-12 |
| Pyrrolidine derivatives as factor XA inhibitors Grant 7,326,785 - Chan , et al. February 5, 2 | 2008-02-05 |
| Piperazinediones as Oxytocin Receptor Antagonists App 20070254888 - Borthwick; Alan David ; et al. | 2007-11-01 |
| Indole derivatives Grant 7,288,564 - Demaine , et al. October 30, 2 | 2007-10-30 |
| Pyrrolidin-2-one derivatives as inhibitors of factor xa Grant 7,282,497 - Chan , et al. October 16, 2 | 2007-10-16 |
| Anthranilic acid derivatives and their use as activators of the hm74a receptor App 20070191378 - Campbell; Matthew ; et al. | 2007-08-16 |
| Substituted diketopiperazines as oxytocin receptor antagonists App 20070185162 - Borthwick; Alan David ; et al. | 2007-08-09 |
| Pyrrolidine Derivatives As Factor Xa Inhibitors App 20070155745 - Chan; Chuen ; et al. | 2007-07-05 |
| Pyrrolidin-2-one derivatives as inhibitors of factor xa Grant 7,226,929 - Chan , et al. June 5, 2 | 2007-06-05 |
| Benzo[F]Isoindole Derivatives With Affinity To The EP4 Receptor App 20070088068 - Congreve; Miles Stuart ; et al. | 2007-04-19 |
| Multivalent neuraminidase inhibitor conjugates Grant 7,205,333 - Wu , et al. April 17, 2 | 2007-04-17 |
| Pyrrolidine derivatives as Factor Xa inhibitors Grant 7,186,717 - Chan , et al. March 6, 2 | 2007-03-06 |
| 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors Grant 7,179,835 - Borthwick , et al. February 20, 2 | 2007-02-20 |
| Pyrrolidin-2-one derivatives as inhibitors of factor Xa Grant 7,084,139 - Chan , et al. August 1, 2 | 2006-08-01 |
| Chemical compounds App 20060160886 - Chan; Chuen ; et al. | 2006-07-20 |
| Chemical compounds App 20060160885 - Chan; Chuen ; et al. | 2006-07-20 |
| 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases App 20060148879 - Borthwick; Alan David ; et al. | 2006-07-06 |
| Naphathalene derivatives which bind to the EP4 receptor Grant 6,924,297 - Giblin , et al. August 2, 2 | 2005-08-02 |
| Substituted diketopiperazines as oxytocin antagonists App 20050148572 - Borthwick, Alan David ; et al. | 2005-07-07 |
| Pyrrolidine derivatives as factor xa inhibitors App 20050107379 - Chan, Chuen ; et al. | 2005-05-19 |
| Benzo'fisoindole derivatives with affinity to the ep4 receptor App 20050080257 - Congreve, Miles Stuart ; et al. | 2005-04-14 |
| Compounds useful in the treatment of inflammatory diseases Grant 6,867,192 - Armour , et al. March 15, 2 | 2005-03-15 |
| 2-(3-Sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors App 20050004119 - Borthwick, Alan David ; et al. | 2005-01-06 |
| Pyrrolidin-2-one derivatives as inhibitors of factor xa App 20040152697 - Chan, Chuen ; et al. | 2004-08-05 |
| Indole derivatives App 20040092569 - Demaine, Derek Anthony ; et al. | 2004-05-13 |
| Multivalent neuraminidase inhibitor conjugates App 20040058853 - Wu, Wen-Yang ; et al. | 2004-03-25 |
| Novel aqueous anti-inflammatory pharmaceutical formulation App 20040044035 - Armour, Duncan Robert ; et al. | 2004-03-04 |
| Pharmaceutical anti-inflammatory aerosol formulation App 20040039021 - Armour, Duncan Robert ; et al. | 2004-02-26 |
| Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist App 20040037784 - Armour, Duncan Robert ; et al. | 2004-02-26 |
| Novel aqueous anti-inflammatory pharmaceutical formulation App 20040034062 - Armour, Duncan Robert ; et al. | 2004-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 